Glaukos
GKOS
#2594
Rank
$6.54 B
Marketcap
$112.77
Share price
0.12%
Change (1 day)
12.72%
Change (1 year)

Operating Margin for Glaukos (GKOS)

Operating Margin as of April 2026 (TTM): -37.12%

According to Glaukos's latest financial reports and stock price the company's current Operating Margin is -37.12%. At the end of 2025 the company had an Operating Margin of -38.04%.

Operating Margin history for Glaukos from 2014 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-38.04%0.19%
2024-37.97%-10.65%
2023-42.49%22.11%
2022-34.80%107.66%
2021-16.76%-71.51%
2020-58.82%178.57%
2019-21.11%209.46%
2018-6.82%-1086637.51%
20170.00%-99.98%
20163.99%-107.47%
2015-53.40%73.4%
2014-30.80%-54.64%
2013-67.89%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
ICU Medical
ICUI
0.19%-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
-9.38%-74.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
-1.13%-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
12.20%-132.88%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.